A case of pathological complete response with liposomal irinotecan + 5-FU/LV for unresectable locally advanced pancreatic cancer

BACKGROUND: Pancreatic cancer has one of the worst prognoses of any all cancers. 5-FU/leucovorin + irinotecan + oxaliplatin (FOLFIRINOX), gemcitabine (GEM) plus nab-paclitaxel regimens have been recognized as global-standard, first-line treatments for patients with advanced pancreatic cancer. The li...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Koji, Umemura, Akira, Nitta, Hiroyuki, Katagiri, Hirokatsu, Nishiya, Masao, Uesugi, Noriyuki, Sugai, Tamotsu, Imanari, Keisuke, Sasaki, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547044/
https://www.ncbi.nlm.nih.gov/pubmed/36205833
http://dx.doi.org/10.1186/s40792-022-01549-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547044/
https://www.ncbi.nlm.nih.gov/pubmed/36205833
http://dx.doi.org/10.1186/s40792-022-01549-9

Ejemplares similares